TLR4 and cancer: On the contrary, Egr acts as a tumor suppressor to drive apoptosis in cancer cells upon activation of Toll/NF-κB signaling by the fat body (adipocytes) in response to the secretion of Egr by the circulating “activated” hemocytes (Parisi et al., 2014).